Karyopharm Therapeutics Inc. (KPTI)
USD 0.66
(-0.65%)
USD 0.66
(-0.65%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -92.72 Million | -149.55 Million | -107.11 Million | -160.23 Million | -190.82 Million | -159.11 Million |
| Net Income | -143.09 Million | -165.29 Million | -124.08 Million | -196.27 Million | -199.59 Million | -178.4 Million |
| Depreciation & Amortization | 530 Thousand | 621 Thousand | 789 Thousand | 972 Thousand | 974 Thousand | 735 Thousand |
| Deferred income taxes | -1.11 Million | - | 1.45 Million | 904 Thousand | -1.38 Million | 29 Thousand |
| Stock-based compensation | 21.7 Million | 35.39 Million | 29.78 Million | 24.4 Million | 15.29 Million | 17.27 Million |
| Change in working capital | 31.41 Million | -19.98 Million | -23.18 Million | 1.35 Million | -13.3 Million | -169 Thousand |
| Other non-cash items | -2.16 Million | -294 Thousand | 8.13 Million | 8.4 Million | 7.19 Million | 1.42 Million |
| Investing Cash Flow | 7.94 Million | -104.25 Million | 141.84 Million | -53.68 Million | 78.45 Million | -107.66 Million |
| Investments in PPE | - | -118 Thousand | -5.71 Million | -145 Thousand | -206 Thousand | -2.36 Million |
| Acquisitions | - | 104.25 Million | 5.5 Million | 53.54 Million | -78.65 Million | - |
| Investment purchases | -159.15 Million | -226.01 Million | -45.22 Million | -274.57 Million | -178.48 Million | -242.81 Million |
| Sales/Maturities of investments | 167.09 Million | 121.87 Million | 192.78 Million | 221.03 Million | 257.14 Million | 137.51 Million |
| Other Investing Activities | 7.94 Million | -104.25 Million | -5.5 Million | -53.54 Million | 78.65 Million | -105.3 Million |
| Financing Cash Flow | 1.12 Million | 193.73 Million | 73.64 Million | 172.08 Million | 124.3 Million | 316.1 Million |
| Debt repayment | - | - | -60 Million | - | - | -166.88 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.12 Million | 193.73 Million | 9.9 Million | 161.77 Million | 46.19 Million | 145.7 Million |
| Other Financing Activities | 1.12 Million | 193.73 Million | 123.74 Million | 10.3 Million | 78.11 Million | 170.4 Million |
| Accounts receivables | 20.12 Million | -5.08 Million | -9.61 Million | -5.01 Million | -7.86 Million | - |
| Accounts payables | 350 Thousand | 1.17 Million | -2.84 Million | 3.46 Million | -3.3 Million | -1.38 Million |
| Inventory | 1.18 Million | -118 Thousand | -1.46 Million | -2.62 Million | -346 Thousand | - |
| Other working capital | 9.76 Million | -15.95 Million | -9.26 Million | 5.53 Million | -1.79 Million | 1.21 Million |
| Cash at beginning of period | 136.25 Million | 197.44 Million | 89.12 Million | 130.68 Million | 118.73 Million | 69.48 Million |
| Cash at end of period | 52.89 Million | 136.88 Million | 197.44 Million | 89.12 Million | 130.68 Million | 118.73 Million |
| Capital Expenditure | - | -118 Thousand | -5.71 Million | -145 Thousand | -206 Thousand | -2.36 Million |
| Effect of forex changes on cash | -34 Thousand | -488 Thousand | -48 Thousand | 268 Thousand | 19 Thousand | -78 Thousand |
| Net cash flow / Change in cash | -83.36 Million | -60.56 Million | 108.32 Million | -41.56 Million | 11.95 Million | 49.25 Million |
| Free Cash Flow | -92.72 Million | -149.67 Million | -112.82 Million | -160.37 Million | -191.02 Million | -161.48 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -32.07 Million | 23.79 Million | -37.36 Million | -143.09 Million | -41.83 Million | -34.5 Million |
| Depreciation & Amortization | -2.02 Million | 91 Thousand | 85 Thousand | 530 Thousand | 77 Thousand | 80 Thousand |
| Deferred income taxes | - | - | - | -1.11 Million | 7.86 Million | -936 Thousand |
| Stock-based compensation | 4.18 Million | 5.41 Million | 4.97 Million | 21.7 Million | 5.18 Million | 5.07 Million |
| Change in working capital | 20.18 Million | -9.47 Million | -10.71 Million | 31.41 Million | 18.79 Million | 549 Thousand |
| Other non-cash items | -9.72 Million | -42.87 Million | 6.37 Million | -2.16 Million | -8.66 Million | 205 Thousand |
| Investing Cash Flow | 7.47 Million | 51.26 Million | 21.94 Million | 7.94 Million | 26.84 Million | -7.68 Million |
| Investments in PPE | - | - | -195 Thousand | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -20.8 Million | -4.9 Million | -31.6 Million | -159.15 Million | -16.55 Million | -46.06 Million |
| Sales/Maturities of investments | 28.27 Million | 56.16 Million | 53.74 Million | 167.09 Million | 43.4 Million | 38.38 Million |
| Other Investing Activities | - | 51.26 Million | 22.13 Million | 7.94 Million | -1.00 | -7.68 Million |
| Financing Cash Flow | - | 40.96 Million | - | 1.12 Million | 264 Thousand | 38.56 Million |
| Debt repayment | -40.19 Million | -40.19 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 111 Million | - | - | - | - | - |
| Common Stock Issuance | 6.92 Million | 772 Thousand | - | 1.12 Million | 264 Thousand | - |
| Other Financing Activities | -118.69 Million | 40.96 Million | - | 1.12 Million | 264 Thousand | - |
| Accounts receivables | 6.21 Million | -6.91 Million | -4.12 Million | 20.12 Million | 10.96 Million | -5.64 Million |
| Accounts payables | 2.98 Million | -2.23 Million | 1.9 Million | 350 Thousand | 2.18 Million | -1.34 Million |
| Inventory | -1.19 Million | -707 Thousand | 274 Thousand | 1.18 Million | 62 Thousand | 567 Thousand |
| Other working capital | 8.39 Million | 377 Thousand | -8.77 Million | 9.76 Million | 5.59 Million | 6.96 Million |
| Cash at beginning of period | 84.8 Million | 31.08 Million | 52.89 Million | 136.25 Million | 44.2 Million | 81.84 Million |
| Cash at end of period | 73.16 Million | 84.8 Million | 31.08 Million | 52.89 Million | 52.89 Million | 44.58 Million |
| Capital Expenditure | - | - | -195 Thousand | - | - | - |
| Effect of forex changes on cash | 36 Thousand | -11 Thousand | -16 Thousand | -34 Thousand | 89 Thousand | -52 Thousand |
| Net cash flow / Change in cash | -11.63 Million | 53.71 Million | -21.8 Million | -83.36 Million | 8.69 Million | -37.26 Million |
| Free Cash Flow | -19.45 Million | -38.49 Million | -43.92 Million | -92.72 Million | -18.58 Million | -29.53 Million |
DSKIF
EIDPARRY
RS
CMGMF
OD6
ADROITINFO